article thumbnail

Swiss scientists identify a virus that kills dormant bacteria

Drug Discovery World

Researchers have found a virus that kills dormant bacteria, a discovery that could help to combat infections that can’t be treated with antibiotics. When tested in cell culture dishes, the virus was able to kill 99% of all dormant bacteria but left 1% alive. They have named their new phage Paride.

Virus 130
article thumbnail

AI identifies drug candidates for respiratory syncytial virus

Drug Discovery World

Potential new drug candidates have been identified by a respiratory syncytial virus (RSV) artificial intelligence programme, as health officials warn of a “tripledemic” of SARS-CoV-2, influenza and RSV. . The post AI identifies drug candidates for respiratory syncytial virus appeared first on Drug Discovery World (DDW).

Virus 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Remission from HIV-1 infection: discovery of broadly neutralizing antibodies that contribute to virus control

SCIENMAG: Medicine & Health

Some HIV-1 carriers who have received an early antiretroviral treatment during several years are able to control the virus for a long term after treatment interruption. For the first time, teams of scientists from the Institut Pasteur, Inserm and the Paris Public Hospital […]

Virus 89
article thumbnail

Vaccine monitoring crucial as SARS-CoV-2 evolves, say researchers

Drug Discovery World

UK researchers have highlighted the importance of continued surveillance of emerging SARS-CoV-2 variants and vaccine performance as the virus continues to evolve. Since the Omicron virus is highly transmissible and the virus replicates in the nose and throat, the researchers tested the levels of antibodies in the participants’ nasal cavity.

Vaccine 130
article thumbnail

A new viral surveillance system in West Africa is showing the world how to prevent the next pandemic

Broad Institute

Sabeti and her lab had also responded quickly to Ebola in 2014, working with hospitals and government officials in Sierra Leone to sequence viral genomes from patients and make the data available to local communities. Ozonoff is also an associate professor of pediatrics at Harvard Medical School and a scientist at Boston Children’s Hospital.

Virus 132
article thumbnail

Most Infants Hospitalized With RSV Were Otherwise Healthy, Study Finds

Drugs.com

15, 2023 -- As experts begin preparing for another season of viruses, they now know that even healthy infants with no underlying health issues are at risk for severe respiratory syncytial virus (RSV). TUESDAY, Aug. New research finds that most.

article thumbnail

GSK’s respiratory syncytial virus

The Pharma Data

RSV causes over 270,000 hospitalisations and approximately 20,000 in-hospital deaths in adults aged 60 years and older each year in Europe. This is the first time an RSV vaccine candidate for adults has gained a positive opinion, one of the final steps in the marketing authorisation procedure prior to approval by the European Commission.

Virus 40